OncoCyte Corporation (OCX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.15
0.00 (0.00%)
At close: Jan 15, 2025, 12:36 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
PE Ratio | -0.69 | -0.48 | -3.01 | -5.23 | -5.17 | -3.32 | -7.25 | -16.75 | -15.03 | -10.52 | -15.01 |
PS Ratio | 12.73 | 37.13 | 24.97 | 128.69 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.75 | 1.04 | 2.96 | 4.67 | 3.74 | 15.26 | 31.89 | 18.96 | 12.60 | -48.84 | 14.51 |
P/FCF Ratio | -0.81 | -0.71 | -5.05 | -5.75 | -5.59 | -4.47 | -10.42 | -24.52 | -27.77 | -44.72 | -71.37 |
P/OCF Ratio | -0.82 | -0.78 | -5.37 | -6.02 | -5.85 | -4.48 | -10.49 | -24.86 | -31.05 | -45.07 | -73.88 |
OCF/S Ratio | -15.52 | -47.57 | -4.65 | -21.37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.11 | 0.10 | 0.09 | 0.26 | 0.19 | 0.50 | 0.57 | 0.05 | 0.08 | -5.48 | 0.82 |
Quick Ratio | 1.49 | 1.93 | 2.75 | 1.03 | 5.17 | 1.55 | 1.91 | 2.97 | 4.72 | 0.49 | 1.04 |
Current Ratio | 1.49 | 2.11 | 2.77 | 1.03 | 5.17 | 1.55 | 1.91 | 2.97 | 4.72 | 0.49 | 1.04 |
Asset Turnover | 0.02 | 0.01 | 0.05 | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -483.38 | -233.73 | -224.62 | -117.9 | -74.38 | -70.38 | -86.86 | -397.86 | -458.84 | -2.49K | n/a |
Return on Equity (ROE) | -1.09 | -2.14 | -0.98 | -0.89 | -0.72 | -4.6 | -4.4 | -1.13 | -0.84 | 4.64 | -0.97 |
Return on Assets (ROA) | -0.37 | -0.73 | -0.4 | -0.54 | -0.56 | -1.66 | -1.9 | -0.77 | -0.69 | -0.78 | -0.42 |
Return on Capital (ROIC) | -0.37 | -0.2 | -0.32 | -0.64 | -0.63 | -3.84 | -3.27 | -1.1 | -0.84 | 4.63 | -0.97 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | -0.01 | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 27.48% | -1.88% | 2.43% | -52.55% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -1.85K% | -7.67K% | -829.52% | -2.46K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -1.65K% | -1.94K% | -949.37% | -2.56K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -1.67K% | -1.88K% | -607.56% | -2.44K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | -1.57K% | -5.21K% | -494.22% | -2.24K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -1.54K% | -1.39K% | -627.11% | -2.51K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |